Redeye shares its preview of Physitrack’s Q1 results, due on 23 April. While recent newsflow regarding new agreements is encouraging, the timing suggests a limited impact on the Q1 figures. We expect the report's highlights to be continued margin expansion and a return to growth for Lifecare ARR.
LÄS MER
